Traders bought shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Tuesday. $69.81 million flowed into the stock on the tick-up and $40.88 million flowed out of the stock on the tick-down, for a money net flow of $28.93 million into the stock. Of all equities tracked, UnitedHealth Group had the 15th highest net in-flow for the day. UnitedHealth Group traded down ($0.54) for the day and closed at $141.08

A number of research analysts recently issued reports on UNH shares. Wedbush restated an “outperform” rating and set a $165.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research report on Friday, July 22nd. Jefferies Group restated a “buy” rating and set a $153.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, May 17th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Finally, Citigroup Inc. boosted their price objective on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research report on Wednesday, July 20th. One investment analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $153.44.

The stock has a market cap of $134.36 billion and a P/E ratio of 22.08. The firm has a 50-day moving average of $141.85 and a 200 day moving average of $131.52.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The company earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. On average, equities research analysts anticipate that UnitedHealth Group Inc. will post $7.91 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th will be given a $0.625 dividend. The ex-dividend date is Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.77%.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Thursday, June 16th. The stock was sold at an average price of $138.58, for a total value of $692,900.00. Following the transaction, the director now directly owns 72,229 shares in the company, valued at approximately $10,009,494.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,500 shares of the firm’s stock in a transaction on Friday, June 10th. The stock was sold at an average price of $139.80, for a total value of $768,900.00. Following the completion of the transaction, the director now owns 59,019 shares in the company, valued at $8,250,856.20. The disclosure for this sale can be found here.

Other hedge funds and institutional investors have bought and sold shares of the company. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in UnitedHealth Group by 2.6% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 10,013 shares of the healthcare conglomerate’s stock valued at $1,178,000 after buying an additional 255 shares in the last quarter. Argent Trust Co raised its position in UnitedHealth Group by 0.5% in the third quarter. Argent Trust Co now owns 13,437 shares of the healthcare conglomerate’s stock valued at $1,559,000 after buying an additional 65 shares in the last quarter. King Luther Capital Management Corp raised its position in UnitedHealth Group by 23.4% in the fourth quarter. King Luther Capital Management Corp now owns 15,723 shares of the healthcare conglomerate’s stock valued at $1,850,000 after buying an additional 2,978 shares in the last quarter. Girard Partners LTD. raised its position in UnitedHealth Group by 17.9% in the fourth quarter. Girard Partners LTD. now owns 18,358 shares of the healthcare conglomerate’s stock valued at $2,160,000 after buying an additional 2,792 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in UnitedHealth Group by 224.8% in the fourth quarter. Victory Capital Management Inc. now owns 18,755 shares of the healthcare conglomerate’s stock valued at $2,206,000 after buying an additional 12,981 shares in the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.